LPS, TLR4 and infectious disease diversity

Nature Reviews Microbiology

Volumn 3, Issue 1, 2005, Pages 36-46

  Miller, Samuel I ^a   Ernst, Robert K ^a   Bader, Martin W ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; FLAGELLIN; INTERLEUKIN 6; LIPID A; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR;

AUTOIMMUNITY; BACTERIAL IMMUNITY; BACTERIAL INFECTION; BORDETELLA; BRUCELLA; CARBOXY TERMINAL SEQUENCE; CELLULAR DISTRIBUTION; CHEMICAL STRUCTURE; DISEASE PREDISPOSITION; DROSOPHILA; ERWINIA; ESCHERICHIA COLI; GENETIC CODE; GENETIC POLYMORPHISM; HELICOBACTER PYLORI; HUMAN; IMMUNE RESPONSE; LEGIONELLA PNEUMOPHILA; MYCOBACTERIUM LEPRAE; NEISSERIA; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SHIGELLA; SPECIES DIFFERENCE; YERSINIA PESTIS;

ANIMALS; ANTIGENS, CD14; ANTIGENS, SURFACE; BACTERIAL INFECTIONS; CARRIER PROTEINS; DISEASE PROGRESSION; DISEASE SUSCEPTIBILITY; HUMANS; IMMUNITY, NATURAL; LIPID A; LIPOPOLYSACCHARIDES; LYMPHOCYTE ANTIGEN 96; MEMBRANE GLYCOPROTEINS; MOLECULAR STRUCTURE; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS;

BACTERIA (MICROORGANISMS); BORDETELLA; BRUCELLA; ERWINIA; ESCHERICHIA COLI; HELICOBACTER; HELICOBACTER PYLORI; LEGIONELLA; LEGIONELLA PNEUMOPHILA; MAMMALIA; MYCOBACTERIUM; MYCOBACTERIUM LEPRAE; NEISSERIA; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SHIGELLA; YERSINIA; YERSINIA PESTIS;

EID: 11144290631     PISSN: 17401526     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrmicro1068     Document Type: Review

References (97)

1. Xu, J. & Gordon, J. I. Inaugural article. Honor thy symbionts. Proc. Natl Acad. Sci. USA 100, 10452-10459 (2003).
2. Janeway, C. A. Jr & Medzhitov, R. Innate immune recognition. Annu. Rev. Immunol. 20, 197-216 (2002).
3. Schnare, M. et al. Toll-like receptors control activation of adaptive immune responses. Nature Immunol. 2, 947-950 (2001).
4. Cha, J. H., Chang, M. Y., Richardson, J. A. & Eidels, L. Transgenic mice expressing the diptheria toxin receptor are sensitive to the toxin. Mol. Microbiol. 49, 235-240 (2003).
5. Lecuit, M. & Cossart, P. Genetically-modified-animal models for human infections: the Listeria paradigm. Trends Mol. Med. 8, 537-542 (2002).
6. Ren, R. & Racaniello, V. R. Human poliovirus receptor gene expression and poliovirus tissue tropism in transgenic mice. J. Virol. 66, 296-304 (1992).
7. Altare, F. et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 280, 1432-1435 (1998).
8. Newport, M. J. et al. A mutation in the interferon-γ-receptor gene and susceptibility to myoobacterial infection. N. Engl. J. Med. 335, 1941-1949 (1996).
9. Lazzaro, B. P., Sceurman, B. K. & Clark, A. G. Genetic basis of natural variation in D. melanogaster antibacterial immunity. Science 303, 1873-1876 (2004).
10. Nimchuk, Z., Eulgem, T., Holt, B. F. & Dangl, J. L. Recognition and response in the plant immune system. Annu. Rev. Genet. 37, 579-609 (2003).
11. Holt, B. F., Hubert, D. A. & Dangl, J. L. Resistance gene signaling in plants - complex similarities to animal innate immunity. Curr. Opin. Immunol. 15, 20-25 (2003).
12. Chang, J. H. Goel, A. K., Grant, S. R. & Dangl, J. L. Wake of the flood: ascribing functions to the wave of type III effector proteins of phytopathogenic bacteria. Curr. Opin. Microbiol. 7, 11-18 (2004).
13. Belkhadir, Y., Subramaniam, R. & Dangl, J. L. Plant disease resistance protein signaling: NBS-LRR proteins and their partners. Curr. Opin. Plant Biol. 7, 391-399 (2004).
14. Guttman, D. S. et al. A functonal screen for the type III (Hrp) secretome of the plant pathogen Pseudomonas syringae. Science 295, 1722-1726 (2002).
15. Chamaillard, M. et al. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nature Immunol. 4, 702-707 (2003).
16. Girardin, S. E. et al. Nod1 detects a unique muropeptide from Gram-negative bacterial peptidoglycan. Science 300, 1584-1587 (2003).
17. Girardin, S. E. et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278, 8869-8872 (2003).
18. Medzhitov, R., Preston-Hurlburt, P. & Janeway, C. A. Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388, 394-397 (1997).
19. Lemaitre, B., Nicolas, E., Michaut, L., Reichhart, J. M. & Hoffmann, J. A. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86, 973-983 (1996).
20. Poltorak, A. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282 2085-2088 (1998).
21. Hayashi, F. et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410, 1099-1103 (2001).
22. Aliprantis, A. O. et al. Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2. Science 285, 736-739 (1999).
23. Hemmi, H. et al. A Toll-like receptor recognizes bacterial DNA. Nature 408, 740-745 (2000).
24. Hell, F. et al. Species-specifc recognition of single-stranded RNA via Toll-like receptor 7 and 8. Science 303 1526-1529 (2004).
25. Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S. & Reis e Sousa, C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303, 1529-1531 (2004).
26. Lund, J. M. et al. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl Acad. Sci. USA 101 5598-5603 (2004).
27. Matsumoto, M. et al. Subcellular localization of Toll-like receptor 3 in human dendritic cells. J. Immunol. 171 3154-3162 (2003).
28. Lee, J. et al. Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of Toll-like receptor 7. Proc. Natl Acad. Sci. USA 100, 6646-6651 (2003).
29. Medzhitov, R. Toll-like receptors and innate immunity. Nature Rev. Immunol. 1, 135-145 (2001).
30. Rakoff-Nahoum, S., Paglino, J., Eslami-Vatzaneh, F., Edberg, S. & Medzhitov, R. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118, 229-241 (2004).
31. Arbour, N. C. et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nature Genet. 25, 187-191 (2000).
32. Lorenz, E., Mira, J. P., Frees, K. L. & Schwartz, D. A. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch. Intern. Med. 162, 1028-1032 (2002).
33. Lorenz, E., Hallman, M., Marttila, R., Haataja, R. & Schwartz, D. A. Association between the Asp299Gly polymorphisms in the Toll-like receptor 4 and premature births in the Finnish population. Pediatr. Res. 52, 373-376 (2002).
34. Torok, H. P., Glas, J., Tonenchi, L., Mussack, T. & Folwaczny, C. Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis. Clin. Immunol. 112, 85-91 (2004).
35. Kiechl, S. et al. Toll-like receptor 4 polymorphisms and atherogenesis. N. Engl. J. Med. 347, 185-192 (2002).
36. Smirnova, I., Poltorak, A., Chan, E. K., McBride, C. & Beutler, B. Phylogenetic variation and polymorphism at the Toll-like receptor 4 locus (TLR4). Genome Biol. 1, R002 (2000).
37. Smirnova, I., Hamblin, M. T., McBride, C., Beutler, B. & Di Rienzo, A. Excess of rare amino acid polymorphisms in the Toll-like receptor 4 in humans. Genetics 158, 1657-1664 (2001).
38. Smirnova, I. et al. Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility. Proc. Natl Acad. Sci. USA 100, 6075-6080 (2003).
39. Picard, C. et al. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 299, 2076-2079 (2003).
40. Bochud, P. Y., Hawn, T. R. & Aderem, A. Cutting edge: a Toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling. J. Immunol. 170, 3451-3454 (2003).
41. Kang, T. J. & Chas, G. T. Detection of Toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients. FEMS Immunol. Med. Microbiol. 31, 53-58 (2001).
42. Hawn, T. R. et al. A common dominant TLR5 stop codon polymorphism abolishes flagellin signalling and is associated with susceptibility to legionnaires' disease. J. Exp. Med. 198, 1563-1572 (2003).
43. Raetz, C. R. & Whitfield, C. Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 71, 635-700 (2002).
44. Angus, D. C. et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29, 1303-1310 (2001).
45. Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J. & Mathison, J. C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249, 1431-1433 (1990).
46. Shimazu, R. et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189, 1777-1782 (1999).
47. Qureshi, S. T. et al. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (TLR4). J. Exp. Med. 189, 615-625 (1999).
48. Hoshino, K. et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the LPS gene product. J. Immunol. 162, 3749-3752 (1999).
49. Nagai, Y. et al. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nature Immunol. 3, 667-672 (2002).
50. Haziot, A., Ferrero, E., Lin, X. Y., Stewart, C. L. & Goyert, S. M. CD14-deficient mice are exquisitely insensitive to the effects of LPS. Prog. Clin. Biol. Res. 392, 349-351 (1995).
51. Hamann, L. et al. A coding mutation within the first exon of the human MD-2 gene results in decreased lipopolysaccharide-induced signaling. Genes Immun., 5, 283-288 (2004).
52. Vogel, S. N., Madonna, G. S., Wahl, L. M. & Rick, P. D. In vitro stimulation of C3H/HeJ spleen cells and macrophages by a lipid A precursor molecule derived from Salmonella typhimurium. J. Immunol. 132, 347-353 (1984).
53. Golenbock, D. T., Hampton, R. Y., Qureshi, N., Takayama, K. & Raetz, C. R. Lipid A-like molecules that antagonize the effects of endotoxins, on human monocytes. J. Biol. Chem. 266, 19490-19498 (1991).
54. Kawasaki, K. et al. Mouse Toll-like receptor 4-MD-2 complex mediates lipopolysaccharide-mimetic signal transduction by taxol. J. Biol. Chem. 275, 2251-2254 (2000).
55. Kawasaki, K., Gomi, K. & Nishijima, M. Cutting edge: Gln22 of mouse MD-2 is essential for species-specific lipopolysaccharide mimetic action of taxol. J. Immunol. 166, 11-24 (2001).
56. Saitoh, S. et al. Lipid A antagonist, lipid IVa, is distinct from Lipid A in interaction with Toll-like receptor 4 (TLR4)-MD-2 and ligand-induced TLR4 oligomerization. Int. Immunol. 16, 961-969 (2004).
57. Akashi, S. et al. Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition. Int. Immunol. 13, 1595-1599 (2001).
58. Hajjar, A. M., Ernst, R. K., Tsai, J. H., Wilson, C. B. & Miller, S. I. Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nature Immunol. 3, 354-359 (2002).
59. Schromm, A. B. et al. The charge of endotoxin molecules influences their conformation and IL-6-inducing capacity. J. Immunol. 161, 5464-5471 (1998).
60. Schromm, A. B. et al. Biological activities of lipopolysaccharides are determined by the shape of their lipid A portion. Eur. J. Biochem. 267, 2008-2013 (2000).
61. Somerville, J. E. Jr, Cassiano, L. & Darveau, R. P. Escherichia coli msbB gene as a virulence factor and a therapeutic target. Infect. Immun. 67, 6583-6590 (1999).
62. Girard, R. et al. Lipopolysaccharides from Legionella and Rhizobium stimulate mouse bone marrow granulocytes via Toll-like receptor 2. J. Cell Sci. 116, 293-302 (2003).
63. Moran, A. P., Lindner, B. & Walsh, E. J. Structural characterization of the lipid A component of Helicobacter pylori rough- and smooth-form lipopolysaccharides. J. Bacteriol. 179 6453-6463 (1997).
64. Smith, M. F. Jr. et al. Toll-like receptor (TLR)2 and TLR5 but not TLR4, are required for Helicobacter pylori-induced NF-κB activation and chemokine expression by epithelial cells. J. Biol. Chem. 278, 32552-32560 (2003).
65. Smith, K. D. et al. Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility. Nature Immunol. 4, 1247-1253 (2003).
66. Lee, S. K. et al. Helicobacter pylori flagellins have very low intrinsic activity to stimulate human gastric epithelial cells via TLR5. Microbes Infect. 5, 1345-1356 (2003).
67. Ernst, R. K., Guina, T. & Miller, S. I. Salmonella typhimurium outer membrane remodeling: role in resistance to host innate immunity. Microbes Infect. 3, 1327-1334 (2001).
68. Hyytiainen, H., Sjoblom, S., Palomaki, T., Tuikkala, A. & Tapio Palva, E. The PmrA-PmrB two-component system responding to acidic pH and iron controls virulence in the plant pathogen Erwinia carotovora ssp. carotovora. Mol. Microbiol. 50, 795-807 (2003).
69. Derzelle, S. et al. The PhoP-PhoQ two-component regulatory system of Photorhabdus luminescens is essential for virulence in insects. J. Bacteriol. 186, 1270-1279 (2004).
70. Hancock, R. E. & Diamond, G. The role of cationic antimicrobial peptides, in innate host defences. Trends Microbiol. 8, 402-410 (2000).
71. Ganz, T. Defensins: antimicrobial peptides of innate immunity. Nature Rev. Immunol. 3, 710-720 (2003).
72. Guo, L. et al. Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell 95 189-198 (1998).
73. Guina, T., Yi, E. C., Wang, H., Hackett, M. & Miller, S. I. A PhoP-regulated outer membrane protease of Salmonella enterica serovar typhimurium promotes resistance to α-helical antimicrobial peptides. J. Bacteriol. 182, 4077-4086 (2000 ).
74. Guo, L. et al. Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ. Science 276, 250-253 (1997).
75. Rebeil, R., Ernst, R. K., Gowen, B. B., Miller, S. I. & Hinnebusch, B. J. Variationin lipid A structure in the pathogenic yersiniae. Mol. Microbiol. 52, 1363-1373 (2004).
76. Apuche Aranda, C. M., Swanson, J. A., Loomis, W. P. & Miller, S. I. Salmonella typhimurium activates virulence gene transcription within acidified macrophage phagosomes. Proc. Natl Acad. Sci. USA 89,10079-10083 (1992).
77. Rosenberger, C. M., Gallo, R. L. & Finlay, B. B. Interplay between antibacterial effectors: a macrophage antimicrobial peptide impairs intracellular Salmonella replication. Proc. Natl Acad. Sci. USA 101, 2422-2427 (2004).
78. Kawasaki, K., Ernst, R. K. & Miller, S. I. 3-O deacylation of lipid A by PagL, a PhoP/PhoQ-regulated deacylase of Salmonella typhimurium, modulates signaling through Toll-like receptor 4. J. Biol. Chem. 279, 20044-20048 (2004).
79. Gunn, J. S. et al. PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance. Mol. Microbiol. 27, 1171-1182 (1998).
80. Trent, M. S., Pabich, W., Raetz, C. R. & Miller, S. I. A PhoP/PhoQ-induced lipase (PagL) that catalyzes 3-O-deacylation of lipid A precursors in membranes of Salmonella typhimurium. J. Biol. Chem. 276, 9083-9092 (2001).
81. 2+/α-ketoglutarate-dependent dioxygenase homologue. J. Biol. Chem. 275, 32940-32949 (2000).
82. Lee, H., Hsu, F. F., Turk, J. & Groisman, E. A. The PmrA-regulated pmrC gene mediates phosphoethanolamine modification of lipid A and polymyxin resistance in Salmonella enterica. J. Bacteriol. 186, 4124-4133 (2004).
83. p-NMR study. Mol. Microbiol. 11, 481-487 (1994).
84. Nummila, K., Kipelainen, I., Zahringer, U., Vaara, M. & Helander, I. M. Lipopolysaacharides of polymyxin B-resistant mutants of Escherichia coli are extensively substituted by 2-aminoethyl pyrophosphate and contain aminoarabinose in lipid A. Mol. Microbiol. 16, 271-278 (1995).
85. Trent, M. S., Ribeiro, A. A., Lin, S., Cotter, R. J. & Raetz, C. R. An inner membrane enzyme in Salmonella and Escherichia coli that transfers 4-amino-4-deoxy-L-arabinose to lipid A: induction on polymyxin-resistant mutants and role of a novel lipid-linked donor. J. Biol. Chem. 276, 43122-43131 (2001).
86. Roland, K. L., Martin, L. E., Esther, C. R. & Spitznagel, J. K. Spontaneous pmrA mutants of Salmonella typhimurium LT2 define a new two-component regulatory system with a possible role in virulence. J. Bacteriol. 175, 4154-4164 (1993).
87. Gunn, J. S., Ryan, S. S., Van Velkinburgh, J. C., Ernst, R. K. & Miller, S. I. Genetic and functional analysis of a PmrA-PmrB-regulated locus necessary for lipopolysaccharide modification, antimicrobial peptide resistance, and oral virulence of Salmonella enterica serovar Typhimurium. Infect. Immun. 68, 6139-6146 (2000).
88. Robey M., O'Connell, W. & Cianciotto, N. P. Identification of Legionella pneumophila rcp, a pagP-like gene that confers resistance to cationic antimicrobial peptides and promotes intracellular infection. Infect. Immun. 69, 4276-A286 (2001).
89. Preston, A. et al. Bordetella bronchiseptica PagP is a Bvg-regulated lipid A palmitoyl transferase that is required for persistent colonization of the mouse respiratory tract. Mol. Microbiol. 48, 725-736 (2003).
90. Ernst, R. K. et al. Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. Science 286 1561-1565 (1999).
91. Coats, S. R., Reife, R. A., Bainbridge, B. W., Pham, T. T. & Darveau, R. P. Porphyromonas gingivalis lipopolysaccharide antagonizes Escherichia coli lipopolysaccharide at Toll-like receptor 4 in human endothelial cells. Infect. Immun. 71, 6799-6807 (2003).
92. Achtman, M. et al. Yersinia pestis, the cause of plague, is a recently emerged clone of Yersnia pseudotuberculosis. Proc. Natl Acad. Sci. USA 96, 14043-14048 (1999).
93. Qureshi, N., Mascagni, P., Ribi, E. & Takayama, K. Monophosphoryl lipid A obtained from lipopolysaccharides of Salmonella minnesota R595. Purification of the dimethyl derivative by high performance liquid chromatography and complete structural determination. J. Biol. Chem. 260, 5271-5278 (1985).
94. Persing, D. H. et al. Taking toll: lipid A mimetics as adjuvants and immunomodulators. Trends Microbiol. 10, S32-S37 (2002).
95. Stover, A. G. et al. Structure-activity relationship of synthetic Toll-like receptor 4 agonists. J. Biol. Chem. 279, 4440-4449 (2004).
96. Hawkins, L. D., Christ, W. J. & Rossignol, D. P. Inhibition of endotoxin response by synthetic TLR4 antagonists. Curr. Top. Med. Chem. 4, 1147-1171 (2004).
97. Baldridge, J. R. et al. Immunostimulatory activity of aminoalkyl glucosaminide 4-phosphates (AGPs): induction of protective innate immune responses by RC-524 and RC-529. J. Endotoxin Res. 8, 453-458 (2002).